首页> 外文期刊>Endocrine journal >Subset analysis of the Japanese risk classification guidelines for papillary thyroid carcinoma
【24h】

Subset analysis of the Japanese risk classification guidelines for papillary thyroid carcinoma

机译:乳头状甲状腺癌日本风险分类指南的子集分析

获取原文
       

摘要

Guidelines published by the Japan Association of Endocrine Surgeons (JAES)/Japanese Society of Thyroid Surgery (JSTS) for patients with papillary thyroid carcinoma describe four risk classes (very low-, low-, intermediate- and high-risk) for deciding on therapeutic strategies. Here, we investigate cause-specific survival (CSS) of high- and intermediate-risk patients, taking their age into consideration. CSS of intermediate-risk patients ≥55 years was poorer than that of those 55 years (p 0.0001) (20-year CSS rates, 96.9% vs. 98.7%). CSS of intermediate-risk patients 55 years was excellent but still poorer (p = 0.0152) than that of low- or very low-risk patients (20-year CSS rates, 100%). CSS of high-risk patients 55 years (20-year CSS rates, 96.0%) was similar (p = 0.7412) to that of intermediate-risk patients ≥55 years, while high-risk patients ≥55 years (20-year CSS rates, 80.6%) showed much poorer prognosis (p 0.0001) than the others. In high-risk patients 55 years, distant metastasis (M1), extrathyroid extension (Ex), node metastasis ≥3 cm, and extranodal tumor extension, and in those ≥55 years, M1, Ex, and tumor size 4 cm were regarded as prognostic factors on multivariate analysis. We therefore conclude that 1) prognosis of high-risk patients ≥55 years should be carefully treated because of significantly poor prognosis, 2) prognostic factors of high-risk patients vary according to patient age, and 3) overtreatment of intermediate-risk patients and young high-risk patients should be avoided; however, appropriate treatment strategies need to be established, considering that their prognoses are excellent, but still poorer than low- or very low-risk patients.
机译:日本内分泌外科医生(JAES)/日本甲状腺手术协会(JSTS)发表的指南,用于乳头状甲状腺癌的患者描述了四种风险课程(非常低,低,中级和高风险),用于决定治疗战略。在这里,我们研究了高级和中等风险患者的原因特异性生存(CSS),以考虑其年龄。中间风险患者的CSS≥55岁比那些<55岁(P <0.0001)(20年CSS率,96.9%vs.98.7%)。中间风险患者的CSS <55年的优异但仍然较差(P = 0.0152),而不是低风险患者(20年CSS率,100%)。高危患者的CSS <55岁(CSS率为96.0%)与中间风险患者≥55岁相似(P = 0.7412),而高风险患者≥55岁(20年CSS速率,80.6%)表现出比其他人更差的预后(P <0.0001)。在高风险患者中<55岁,远处转移(M1),脱滴虫延伸(ex),节点转移≥3厘米和外肿瘤延伸,以及在≥55岁,M1,EX和肿瘤大小> 4厘米被视为多元分析的预后因素。因此,我们得出结论,高危患者的预后≥55岁,应仔细治疗,因为预后显着差,2)高风险患者的预后因素根据患者年龄而变化,3)患有中间风险患者的过处应避免年轻高风险患者;然而,考虑到他们的预期是优秀的,但仍然比低风险或非常低风险的患者仍然较差,需要建立适当的治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号